What Does the GMC Say About Prescribing Cannabis-Based Products?
Medical cannabis is increasingly talked about in the UK, with patients hoping it will relieve conditions https://smoothdecorator.com/how-do-i-find-a-straight-answer-on-uk-medical-cannabis-without-the-politics/ like chronic pain or epilepsy. However, the reality of accessing cannabis-based products through the NHS or private clinics is complex. The General Medical Council (GMC) sets out clear rules and guidance for doctors about prescribing these treatments responsibly.
In this blog post, we'll break down what medical cannabis actually means, explain the UK legal and regulatory framework, and clarify the differences between private clinic pathways and NHS prescribing realities. We'll also cover the important concept of unlicensed medicines and the specialist judgment required under GMC standards.
What is Medical Cannabis?
Medical cannabis refers to cannabis or cannabis-derived products (CBPMs) used to treat specific medical conditions. These products include a range of pharmaceutical formulations containing cannabinoids like THC (tetrahydrocannabinol) and CBD (cannabidiol), which can affect the body’s nervous system.
Here is the bit people miss: medical cannabis is not the same as recreational cannabis or "weed," which is illegal in the UK. Medical cannabis products prescribed by doctors are highly regulated and often part of specialist treatment plans.
Types of Cannabis-Based Products
- Licensed medicines: These are cannabis-based products that have been approved by the UK medicines regulator (MHRA) and have a designated marketing authorisation. Examples include Epidyolex for epilepsy.
- Unlicensed cannabis-based products: These are prescribed when no licensed option matches a patient's needs. They don't have full marketing approval but can be prescribed under specialist judgment and certain safety standards.
UK Legality and Regulated Prescribing of Medical Cannabis
In November 2018, the UK government legalised the prescription of cannabis-based products for medicinal use by specialist doctors in very limited circumstances. Before then, patients could not access cannabis treatments regulated cannabis products UK legally on prescription in the UK.
The key points on legality are:
- Only specialist doctors on the General Medical Council’s specialist register can prescribe cannabis-based products for medicinal use.
- Prescribing on the NHS is very rare and reserved for exceptional cases where other treatments have failed.
- Private clinics can prescribe cannabis-based products more readily, although the GMC’s standards still apply.
- Cannabis is still a controlled drug under the Misuse of Drugs Act 1971, so misuse or inappropriate prescribing carries legal consequences.
GMC Medical Cannabis Guidance: Responsible Prescribing of Unlicensed Medicines
The General Medical Council is the professional regulator for doctors in the UK. Its guidance on prescribing cannabis-based products focusses heavily on responsible prescribing, particularly when unlicensed medicines are involved.
Here is the bit people miss: Most cannabis-based products available currently in the UK are unlicensed medicines. This means they don’t have the usual approvals that licensed medicines get to prove safety and effectiveness. The GMC expects doctors to apply rigorous specialist judgment when prescribing these products.
Key Points from GMC Guidance
- Specialist assessment: Only doctors with relevant expertise should prescribe medical cannabis, ensuring the patient’s condition justifies it.
- Informed consent: Patients must receive clear, balanced information about potential benefits, risks, and uncertainties related to cannabis treatments.
- Monitoring and review: Doctors must carefully monitor patients’ responses and side effects and be prepared to stop treatment if necessary.
- Record keeping: Detailed clinical records are essential for prescribing unlicensed cannabis-based products.
- Use of licensed medicines preferable: If a licensed alternative exists, it should be tried before considering unlicensed cannabis products.
Private Clinic Pathway vs NHS Prescribing Reality
Access to medical cannabis is quite different depending on whether a patient uses the NHS or a private specialist clinic.
NHS Prescribing Pathway
I've seen this play out countless times: thought they could save money but ended up paying more.. The NHS takes a cautious approach. Prescribing cannabis-based products on the NHS remains very limited and is typically restricted to conditions like certain types of severe epilepsy and terminal cancer pain when other treatments have failed.
Patients hoping for cannabis treatment on the NHS often face:
- Long waiting lists to see a specialist who can assess eligibility
- Stringent clinical criteria and pathways
- Limited options for products—mostly licensed medicines like Epidyolex
- Comprehensive monitoring and follow-up
Private Clinic Prescribing Pathway
You ever wonder why in contrast, private clinics specialising in cannabis medications offer quicker access. They tend to:
- Provide consultations more rapidly, sometimes online
- Prescribe a broader range of cannabis-based products, including unlicensed options
- Have shorter prescription renewal cycles but usually at a significant out-of-pocket cost
- Still adhere to GMC standards for specialist prescribing and patient safety
While private clinics may seem more accessible, the GMC emphasises that doctors must still act cautiously and follow responsible prescribing standards for unlicensed cannabis products, regardless of private or NHS setting.
The Role of Specialist Judgement in Prescribing Cannabis
Here is the bit people miss: Medical cannabis prescribing is never a routine decision. The GMC requires doctors to apply specialist clinical judgment carefully, considering the individual patient’s condition, previous treatments, and evidence available.
Doctors should consider:
- The quality and limitations of clinical research supporting cannabis use for specific conditions
- The risks of potential side effects (e.g., dependency, cognitive effects)
- The patient’s wider medical and psychological background
- Legal and ethical duties to prescribe responsibly
This specialist judgment becomes even more critical when prescribing unlicensed medicines. The GMC’s Good Medical Practice guidance expects doctors to act within their competence https://bizzmarkblog.com/what-does-a-specialist-private-clinic-mean-in-the-uk-medical-cannabis-world/ and only prescribe unlicensed medicines when no suitable licensed alternative exists.
Summary Table: NHS vs Private Post-2018 Medical Cannabis Prescribing
Aspect NHS Private Specialist Clinics Prescribing doctors Specialists on GMC specialist register Specialists, often with cannabis expertise Access speed Slow; long waiting times Faster, often online consultations Available products Mostly licensed medicines (e.g., Epidyolex) Wider selection including unlicensed products Cost to patient Usually free at point of use Out-of-pocket, often expensive Prescribing restrictions Strict clinical criteria, limited conditions More flexible but within GMC guidelines Monitoring Close follow-up and specialist review Required but variable, depends on clinic
Final Thoughts
The GMC medical cannabis guidance makes clear that doctors must prescribe these treatments with care, specialist knowledge, and clear communication with patients. While private clinics offer more rapid access to a variety of cannabis-based products, prescribing always carries accountability under the GMC’s professional standards.
If you're considering medical cannabis, your best first step is to speak with your GP about referral to a specialist on the NHS who understands the regulations and clinical evidence. If you explore private clinics, make sure the doctor is registered and works responsibly under the GMC’s guidance for unlicensed medicines and specialist prescribing standards.
Ultimately, medical cannabis is not a simple quick fix, but a carefully considered treatment choice requiring specialist judgement and close monitoring.
